Bruker Current Ratio 2010-2024 | BRKR
Current and historical current ratio for Bruker (BRKR) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bruker current ratio for the three months ending March 31, 2024 was .
| Bruker Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-03-31 |
$2.14B |
$1.18B |
1.81 |
| 2023-12-31 |
$2.16B |
$1.20B |
1.80 |
| 2023-09-30 |
$2.03B |
$1.07B |
1.89 |
| 2023-06-30 |
$2.18B |
$1.05B |
2.08 |
| 2023-03-31 |
$2.13B |
$1.05B |
2.03 |
| 2022-12-31 |
$2.11B |
$0.91B |
2.31 |
| 2022-09-30 |
$2.04B |
$0.87B |
2.36 |
| 2022-06-30 |
$2.09B |
$0.82B |
2.55 |
| 2022-03-31 |
$2.25B |
$0.88B |
2.56 |
| 2021-12-31 |
$2.47B |
$0.94B |
2.63 |
| 2021-09-30 |
$1.99B |
$0.92B |
2.16 |
| 2021-06-30 |
$1.97B |
$0.96B |
2.06 |
| 2021-03-31 |
$1.95B |
$0.94B |
2.06 |
| 2020-12-31 |
$1.93B |
$0.79B |
2.43 |
| 2020-09-30 |
$1.83B |
$0.68B |
2.67 |
| 2020-06-30 |
$1.96B |
$0.75B |
2.61 |
| 2020-03-31 |
$1.99B |
$0.77B |
2.60 |
| 2019-12-31 |
$1.80B |
$0.65B |
2.78 |
| 2019-09-30 |
$1.43B |
$0.64B |
2.23 |
| 2019-06-30 |
$1.41B |
$0.64B |
2.19 |
| 2019-03-31 |
$1.34B |
$0.63B |
2.12 |
| 2018-12-31 |
$1.30B |
$0.60B |
2.18 |
| 2018-09-30 |
$1.26B |
$0.56B |
2.24 |
| 2018-06-30 |
$1.18B |
$0.53B |
2.22 |
| 2018-03-31 |
$1.24B |
$0.56B |
2.22 |
| 2017-12-31 |
$1.36B |
$0.53B |
2.59 |
| 2017-09-30 |
$1.34B |
$0.51B |
2.60 |
| 2017-06-30 |
$1.30B |
$0.49B |
2.63 |
| 2017-03-31 |
$1.26B |
$0.52B |
2.46 |
| 2016-12-31 |
$1.28B |
$0.53B |
2.43 |
| 2016-09-30 |
$1.27B |
$0.55B |
2.29 |
| 2016-06-30 |
$1.22B |
$0.54B |
2.27 |
| 2016-03-31 |
$1.23B |
$0.54B |
2.26 |
| 2015-12-31 |
$1.23B |
$0.56B |
2.22 |
| 2015-09-30 |
$1.39B |
$0.68B |
2.05 |
| 2015-06-30 |
$1.36B |
$0.65B |
2.08 |
| 2015-03-31 |
$1.31B |
$0.54B |
2.41 |
| 2014-12-31 |
$1.37B |
$0.58B |
2.35 |
| 2014-09-30 |
$1.40B |
$0.61B |
2.30 |
| 2014-06-30 |
$1.47B |
$0.63B |
2.33 |
| 2014-03-31 |
$1.48B |
$0.67B |
2.20 |
| 2013-12-31 |
$1.43B |
$0.65B |
2.21 |
| 2013-09-30 |
$1.37B |
$0.65B |
2.12 |
| 2013-06-30 |
$1.26B |
$0.60B |
2.10 |
| 2013-03-31 |
$1.28B |
$0.64B |
1.99 |
| 2012-12-31 |
$1.31B |
$0.68B |
1.92 |
| 2012-09-30 |
$1.25B |
$0.69B |
1.81 |
| 2012-06-30 |
$1.21B |
$0.75B |
1.61 |
| 2012-03-31 |
$1.25B |
$0.77B |
1.61 |
| 2011-12-31 |
$1.19B |
$0.76B |
1.58 |
| 2011-09-30 |
$1.17B |
$0.92B |
1.27 |
| 2011-06-30 |
$1.17B |
$0.90B |
1.29 |
| 2011-03-31 |
$1.12B |
$0.87B |
1.28 |
| 2010-12-31 |
$1.05B |
$0.83B |
1.26 |
| 2010-09-30 |
$0.95B |
$0.59B |
1.61 |
| 2010-06-30 |
$0.84B |
$0.54B |
1.54 |
| 2010-03-31 |
$0.87B |
$0.54B |
1.61 |
| 2009-12-31 |
$0.87B |
$0.54B |
1.62 |
| 2009-09-30 |
$0.82B |
$0.52B |
1.57 |
| 2009-06-30 |
$0.79B |
$0.52B |
1.52 |
| 2009-03-31 |
$0.77B |
$0.49B |
1.57 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$10.180B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
